Wells Fargo’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,100
Closed -$179K 7125
2021
Q4
$179K Buy
+2,100
New +$164K ﹤0.01% 5326
2019
Q3
Sell
-100,000
Closed -$154K 6389
2019
Q2
$154K Buy
+100,000
New +$7.1M ﹤0.01% 5112
2019
Q1
Sell
-350,000
Closed -$12K 6074
2018
Q4
$12K Sell
350,000
-57,800
-14% -$3.62M ﹤0.01% 5887
2018
Q3
$167K Buy
+407,800
New +$27.2M ﹤0.01% 5092
2018
Q1
Sell
-59,500
Closed -$51K 6372
2017
Q4
$51K Buy
+59,500
New +$4.34M ﹤0.01% 5551
2017
Q2
Sell
-120,000
Closed -$71K 6240
2017
Q1
$71K Buy
+120,000
New +$8.4M ﹤0.01% 5329
2016
Q4
Sell
-1,500
Closed -$2K 6262
2016
Q3
$2K Buy
+1,500
New +$111K ﹤0.01% 6037

Other funds holding CL

Wells Fargo's CL Position: Q1 2026 in Review

Wells Fargo increased its Colgate-Palmolive (CL) stake by 4% in Q1 2026, buying an estimated $14.1M and bringing the position to 4,125,666 shares worth $352M. The position accounts for 0.07% of the portfolio, ranked #255.

Wells Fargo first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $816M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Wells Fargo held 4,125,666 shares of Colgate-Palmolive worth $352M as of Q1 2026.
  • Wells Fargo bought 158,255 Colgate-Palmolive shares in Q1 2026, an estimated $14.1M.
  • Colgate-Palmolive made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #255 holding.
  • Wells Fargo first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Colgate-Palmolive position peaked at $816M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.